Stroke ranks among the leading causes for morbidity and mortality worldwide. New and
continuously improving treatment options such as thrombolysis and thrombectomy have …

Purpose—To critically review and evaluate the science behind individual eligibility criteria
(indication/inclusion and contraindications/exclusion criteria) for intravenous recombinant …

Background and Purpose—Several risk factors are known to increase mid-and long-term
mortality of ischemic stroke patients. Information on predictors of early stroke mortality is …

Stroke is among the leading causes of death and disability worldwide. Approximately 20–
25% of stroke survivors present severe disability, which is associated with increased …

Stroke remains one of the main causes of death and disability worldwide. The challenge of
predicting stroke outcome has been traditionally assessed from a general point of view …

Background: There are many prognostic scales that aim to predict functional outcome
following acute stroke. Despite considerable research interest, these scales have had …

Background and purpose The modified Rankin Scale (mRS) was designed to measure
poststroke recovery but is often used to describe pre-stroke disability. We sought to evaluate …

Background and Purpose—Several stroke prognostic scores have been developed to
predict clinical outcomes after stroke. This study aimed to develop and validate novel data …

Background and Purpose—Patients with premorbid disability, generally defined as modified
Rankin Scale (mRS) score≥ 2, are often excluded from trials of acute stroke therapies …

Objective: To measure the association of B-type natriuretic peptide (BNP) and N-terminal
fragment of BNP (NT-proBNP) with all-cause mortality after stroke, and to evaluate the …